$ATRA
Atara Biotherapeutics, Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Atara Biotherapeutics, Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ATRA down today? It is at $6.33 (-0.16%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ATRA spikes, and full due diligence on ATRA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ATRA 11 times in the last 30 days. Create a free account to track $ATRA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ATRA traded in the last session, Friday (last price and move above). Our scanner fired 2 unusual-volume and momentum alerts on ATRA on Friday, peaking at 18.5x its normal volume.
Likely catalystAtara Biotherapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 18, 2026 · 3 days agoAcross every filing on file, supply equal to at least 33.3% of the tradeable float is in play - 33.3% more can still be issued.
Some filings did not state a size, so these are floors.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Nguyen Anhco Officer | Sold (automatic/other) | -6K 0.06% of company | sold 4.6% | 127K | $39K at $6.46 | Nov 16, 26 |
Cherry Brian N Director | Bought (open market) | +104K 1.0% of company | added 100% | 166K | $1000K at $9.60 | Sep 4, 26 |
Nguyen Anhco Officer | Sold (automatic/other) | -5K 0.05% of company | sold 3.7% | 133K | $41K at $8.08 | Aug 17, 26 |
Redmile Group, Llc Director | Sold (automatic/other) | -60 | sold <0.1% | 637K | n/a | Jul 22, 26 |
Redmile Group, Llc Director | Other | 195K 1.9% of company | added 44% | 637K | n/a | Jul 22, 26 |
Cherry Brian N Director | Acquired (grant/award) | +24K 0.2% of company | added 63% | 62K | n/a | Jun 11, 26 |
Ciongoli Gregory Austin Director | Acquired (grant/award) | +12K 0.1% of company | n/a | 12K | n/a | Jun 9, 26 |
Fust Matthew K Director | Acquired (grant/award) | +12K 0.1% of company | added 66% | 30K | n/a | Jun 9, 26 |
Heiden William K Director | Acquired (grant/award) | +12K 0.1% of company | added 54% | 34K | n/a | Jun 9, 26 |
Grant-Huerta Yanina Officer | Sold (automatic/other) | -2K 0.02% of company | sold 4.6% | 50K | $22K at $9.13 | May 18, 26 |
Nguyen Anhco Officer | Sold (automatic/other) | -5K 0.05% of company | sold 3.7% | 138K | $48K at $9.13 | May 18, 26 |
Ecor1 Capital, Llc Beneficial Owner (10%) | Bought (open market) | +507K 5.0% of company | added 49% | 1.55M | $4.7M at $9.35 | May 7, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
The market is closed. Here is how ATRA traded in the last session, Friday (last price and move above). Our scanner fired 2 unusual-volume and momentum alerts on ATRA on Friday, peaking at 18.5x its normal volume.
ATRA last traded at $6.33, down 0.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ATRA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ATRA 11 times in the last 30 days.
ATRA (Atara Biotherapeutics, Inc) trades on XNAS, with a market cap of about $64M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ATRA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ATRA discussion
Sign in to ask a question or join the discussion.